Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…